Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Kai-Lung CHEN"'
Autor:
Shao-Hsuan Hsu, Che-Wen Yang, Yi-Chun Hsieh, Kai-Lung Chen, Yung-Tsu Cho, Jau-Yu Liau, Chia-Yu Chu
Publikováno v:
Dermatologica Sinica, Vol 39, Iss 4, Pp 175-181 (2021)
Background: Plasmacytoid dendritic cells (pDCs) are implicated in the reactivation of human herpesvirus 6 (HHV-6) in drug reaction with eosinophilia and systemic symptoms (DRESS). Objectives: We aimed at identifying the alterations of circulating pDC
Externí odkaz:
https://doaj.org/article/7216b93cffe04260a3968abff46d9404
Publikováno v:
Biomedicines, Vol 10, Iss 5, p 1197 (2022)
Pemphigus is an autoantibody-mediated blistering disease. In addition to conventional pemphigus vulgaris and pemphigus foliaceus, several other types have been reported. Among them, IgG/IgA pemphigus is less well defined and seldom reported. To chara
Externí odkaz:
https://doaj.org/article/6b59cf25d8fa43b687c1dabc59d77240
Autor:
Hsien-Yi Chiu, Rosaline Chung-Yee Hui, Yu-Huei Huang, Ruey-Yun Huang, Kai-Lung Chen, Ya-Chu Tsai, Po-Ju Lai, Ting-Shun Wang, Tsen-Fang Tsai
Publikováno v:
Acta Dermato-Venereologica, Vol 98, Iss 9, Pp 829-834 (2018)
Safety data for secukinumab in patients with psoriasis and viral hepatitis are lacking. The aim of this study is to investigate the risk of reactivation of hepatitis B virus (HBV)/hepatitis C virus (HCV) in patients with psoriasis who are receiving s
Externí odkaz:
https://doaj.org/article/ff5f8765c60c479fbf439d2b680db8c6
Autor:
Kai-Lung Chen, Hsien-Yi Chiu, Jui-Hsiang Lin, Jian-De Ye, Yi-Hsuan Cho, Ko-Jen Li, Tsen-Fang Tsai
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 10 (2019)
Background: Multiple comorbidities, including rheumatoid arthritis (RA), have been reported to be associated with psoriasis. Objective: This study aimed to determine the prevalence and the clinical features of RA among patients with psoriasis in a te
Externí odkaz:
https://doaj.org/article/7d1296b66e3549a4a06f902c9f7f0613
Publikováno v:
Dermatologica Sinica, Vol 34, Iss 2, Pp 102-105 (2016)
Fibrous histiocytoma is a common benign cutaneous tumor. Although most cases of fibrous histiocytoma pursue an indolent course, rare cases have been reported that show aggressive courses with metastases and fatality despite a benign pathology. Here,
Externí odkaz:
https://doaj.org/article/12240ae276fa446785987d9cab10b8e7
Autor:
Kai-Lung Chen
Publikováno v:
Dermatologica Sinica, Vol 34, Iss 4, Pp 211-212 (2016)
Externí odkaz:
https://doaj.org/article/7d0c5c15dcb04336832aeee7aa594852
Publikováno v:
Dermatologica Sinica, Vol 34, Iss 3, Pp 166-167 (2016)
Externí odkaz:
https://doaj.org/article/6faff9cc1b6641d09e63e450a29b8775
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADVREFERENCES.
Epidermal growth factor receptor (EGFR) inhibitors are selective and effective treatments for cancers with relevant mutations. Purpuric drug eruptions are an uncommon but clinically significant dermatological side effect related to EGFR inhibitor use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23ff47b60df4f080e7ed1eff07e191d0
https://pubmed.ncbi.nlm.nih.gov/36200415
https://pubmed.ncbi.nlm.nih.gov/36200415
Publikováno v:
The British journal of dermatologyReferences. 183(5)
BACKGROUND Drug reaction with eosinophilia and systemic symptoms (DRESS) is a condition caused by a drug-induced immune response. Previous reports have found that CXCL10, also known as interferon-γ-induced protein (IP)-10, may participate in the pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c8ba2d41c75397d2de85a3205775268
https://pubmed.ncbi.nlm.nih.gov/32338373
https://pubmed.ncbi.nlm.nih.gov/32338373
Autor:
Po-Ju Lai, Rosaline Chung-Yee Hui, Kai-Lung Chen, Ruey-Yun Huang, Hsien-Yi Chiu, Ya-Chu Tsai, Yu-Huei Huang, Ting-Shun Wang, Tsen-Fang Tsai
Publikováno v:
Acta Dermato-Venereologica, Vol 98, Iss 9, Pp 829-834 (2018)
Safety data for secukinumab in patients with psoriasis and viral hepatitis are lacking. The aim of this study is to investigate the risk of reactivation of hepatitis B virus (HBV)/hepatitis C virus (HCV) in patients with psoriasis who are receiving s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6a21090cf19bba5a1bad63944ee29d2
https://doi.org/10.2340/00015555-2989
https://doi.org/10.2340/00015555-2989